Cargando…
In Vitro Phenotypic Activity and In Silico Analysis of Natural Products from Brazilian Biodiversity on Trypanosoma cruzi
Chagas disease (CD) affects more than 6 million people worldwide. The available treatment is far from ideal, creating a demand for new alternative therapies. Botanical diversity provides a wide range of novel potential therapeutic scaffolds. Presently, our aim was to evaluate the mammalian host toxi...
Autores principales: | Peres, Raiza B., Fiuza, Ludmila F. de A., da Silva, Patrícia B., Batista, Marcos M., Camillo, Flávia da C., Marques, André M., de C. Brito, Lavínia, Figueiredo, Maria R., Soeiro, Maria de N. C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8472459/ https://www.ncbi.nlm.nih.gov/pubmed/34577145 http://dx.doi.org/10.3390/molecules26185676 |
Ejemplares similares
-
Antiparasitic Activity of Plumbago auriculata Extracts and Its Naphthoquinone Plumbagin against Trypanosoma cruzi
por: Peres, Raiza Brandão, et al.
Publicado: (2023) -
Combination With Tomatidine Improves the Potency of Posaconazole Against Trypanosoma cruzi
por: Rocha-Hasler, Marianne, et al.
Publicado: (2021) -
Efficacy of sertraline against Trypanosoma cruzi: an in vitro and in silico study
por: Ferreira, Daiane Dias, et al.
Publicado: (2018) -
In vitro and in silico analysis of imatinib analogues as anti-Trypanosoma cruzi drug candidates
por: Nesic de Freitas, Luca S. F., et al.
Publicado: (2023) -
Phenotypic Evaluation of Nucleoside Analogues against Trypanosoma cruzi Infection: In Vitro and In Vivo Approaches
por: Fiuza, Ludmila F. de A., et al.
Publicado: (2022)